148 related articles for article (PubMed ID: 1158034)
1. Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes mellitus.
Colwell JA; Chambers A; Laimins M
Diabetes; 1975 Jul; 24(7):684-7. PubMed ID: 1158034
[TBL] [Abstract][Full Text] [Related]
2. Acetylenic analog of arachidonate that acts like aspirin on platelets.
Willis AL; Kuhn DC; Weiss HJ
Science; 1974 Jan; 183(4122):327-30. PubMed ID: 4809077
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 potentiation of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion.
Weiss HJ; Willis AL; Kuhn D; Brand H
Br J Haematol; 1976 Feb; 32(2):257-72. PubMed ID: 1247498
[TBL] [Abstract][Full Text] [Related]
4. Altered platelet function in diabetes mellitus.
Colwell JA; Halushka PV; Sarji K; Levine J; Sagel J; Nair RM
Diabetes; 1976; 25(2 SUPPL):826-31. PubMed ID: 823064
[TBL] [Abstract][Full Text] [Related]
5. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.
Halushka PV; Lurie D; Colwell JA
N Engl J Med; 1977 Dec; 297(24):1306-10. PubMed ID: 917087
[TBL] [Abstract][Full Text] [Related]
6. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.
Willis AL; Comai K; Kuhn DC; Paulsrud J
Prostaglandins; 1974 Dec; 8(6):509-19. PubMed ID: 4462154
[No Abstract] [Full Text] [Related]
7. An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance.
Willis AL; Vane FM; Kuhn DC; Scott CG; Petrin M
Prostaglandins; 1974 Dec; 8(6):453-507. PubMed ID: 4471695
[No Abstract] [Full Text] [Related]
8. Novel effects of epoxyeicosatrienoic acid isomers: inhibition of platelet aggregation and cyclooxygenase activity.
Fitzpatrick FA; Ennis MD; Baze ME
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():109-14. PubMed ID: 2959037
[No Abstract] [Full Text] [Related]
9. Labile aggregation stimulating substance, free fatty acids, and platelet aggregation.
Gerrard JM; White JG; Krivit W
J Lab Clin Med; 1976 Jan; 87(1):73-82. PubMed ID: 1245785
[TBL] [Abstract][Full Text] [Related]
10. Increased platelet aggregation in early diabetus mellitus.
Sagel J; Colwell JA; Crook L; Laimins M
Ann Intern Med; 1975 Jun; 82(6):733-8. PubMed ID: 1138583
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular disease.
Jakubowski JA; Ardlie NG
Thromb Res; 1979; 16(1-2):205-17. PubMed ID: 388720
[No Abstract] [Full Text] [Related]
12. Increased platelet arachidonic acid metabolism in diabetes mellitus.
Halushka PV; Mayfield R; Wohltmann HJ; Rogers RC; Goldberg AK; McCoy SA; Loadholt CB; Colwell JA
Diabetes; 1981; 30(Suppl 2):44-8. PubMed ID: 6795072
[TBL] [Abstract][Full Text] [Related]
13. Butyltin compounds in vitro inhibition of human platelet epinephrine-induced aggregation and blockade of epinephrine binding to platelets.
Yanagisawa H; Wada O
Ind Health; 1985; 23(4):255-68. PubMed ID: 3938784
[No Abstract] [Full Text] [Related]
14. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
[TBL] [Abstract][Full Text] [Related]
15. Sulfonylureas and platelet function.
Klaff LJ; Kernoff L; Vinik AI; Jackson WP; Jacobs P
Am J Med; 1981 Mar; 70(3):627-30. PubMed ID: 6782875
[TBL] [Abstract][Full Text] [Related]
16. [Thrombocytopathia with cyclo-oxygenase deficiency].
Dechavanne M; Lagarde M; Bryon PA
Nouv Rev Fr Hematol (1978); 1976; 16(3):421-6. PubMed ID: 827736
[TBL] [Abstract][Full Text] [Related]
17. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
18. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
Smith JB; Ingerman CM; Silver MJ
J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
[TBL] [Abstract][Full Text] [Related]
19. Biphasic effects of phospholipase A2 on platelet aggregation. Effect of prostaglandin synthesis inhibitors and essential fatty acid deficiency.
Vincent JE; Zijlstra FJ
Prostaglandins; 1976 Dec; 12(6):971-9. PubMed ID: 1005744
[TBL] [Abstract][Full Text] [Related]
20. Platelet adhesion and aggregation in diabetes mellitus.
Colwell JA; Nair RM; Halushka PV; Rogers C; Whetsell A; Sagel J
Metabolism; 1979 Apr; 28(4 Suppl 1):394-400. PubMed ID: 122293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
